14-((Tetrahydro-2H-pyran-2-yl)oxy)-3,6,9,12-tetraoxatetradecyl 4-methylbenzenesulfonate

Catalog No. :
ACTOZN354
CAS No. :
1549752-65-9
Molecular Formula :
C22H36O9S
Molecular Weight :
476.59

IUPAC Name:14-((tetrahydro-2H-pyran-2-yl)oxy)-3,6,9,12-tetraoxatetradecyl 4-methylbenzenesulfonate

14-((Tetrahydro-2H-pyran-2-yl)oxy)-3,6,9,12-tetraoxatetradecyl 4-methylbenzenesulfonate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name14-((Tetrahydro-2H-pyran-2-yl)oxy)-3,6,9,12-tetraoxatetradecyl 4-methylbenzenesulfonate
IUPAC Name14-((tetrahydro-2H-pyran-2-yl)oxy)-3,6,9,12-tetraoxatetradecyl 4-methylbenzenesulfonate
Molecular FormulaC22H36O9S
Molecular Weight476.59
SMILESCC1=CC=C(S(=O)(=O)OCCOCCOCCOCCOCCOC2CCCCO2)C=C1
InChI KeyQWYSLDAOPKGABA-UHFFFAOYSA-N
Synonym3,6,9,12-Tetraoxatetradecan-1-ol, 14-[(tetrahydro-2H-pyran-2-yl)oxy]-, 1-(4-methylbenzenesulfonate)
CAS No.1549752-65-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACTOZN354 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKMBZ870 route compound structure diagram
    ACKMBZ870146395-14-4 In Stock
  4. Then
  5. ACTOZN354 route product structure diagram
    ACTOZN3541549752-65-9
Inquiry

2. ACTOZN354 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXUTM817 route compound structure diagram
    ACXUTM817128660-97-9 In Stock
  4. Then
  5. ACTOZN354 route product structure diagram
    ACTOZN3541549752-65-9
Inquiry

Comments (0)